Dr Reddy's Launches Generic Anti-Bacterial Drug in US
May 03, 2024 16:11
Dr Reddy's Laboratories has launched a generic Doxycycline Capsules (40 mg) in the US market, a therapeutic equivalent of Oracea capsules (40 mg).
New Delhi, May 3 (PTI) Dr Reddy's Laboratories on Friday said it has launched a generic medication, used to treat a wide variety of bacterial infections, in the US market.
The company has launched Doxycycline Capsules (40 mg) in the US market, the Hyderabad-based drug maker said in a statement.
The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration (USFDA).
Shares of the company on Friday ended 0.71 per cent up at Rs 6,332.85 apiece on the BSE.
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.